GAM
ABCL icon

Gotham Asset Management’s AbCellera Biologics ABCL Stock Holding History

Gotham Asset Management’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-46,090
Closed -$298K – 1314
2023
Q2 		$298K Sell
46,090
-77,174
-63% -$527K 0.01% 1126
2023
Q1 		$929K Buy
123,264
+7,162
+6% +$65K 0.02% 770
2022
Q4 		$1.18M Buy
116,102
+37,464
+48% +$433K 0.03% 623
2022
Q3 		$778K Buy
+78,638
New +$863K 0.02% 736
2022
Q1 		– Sell
-28,415
Closed -$406K – 1114
2021
Q4 		$406K Sell
28,415
-44,652
-61% -$678K 0.01% 847
2021
Q3 		$1.46M Buy
73,067
+47,579
+187% +$841K 0.06% 382
2021
Q2 		$561K Buy
+25,488
New +$703K 0.02% 653

Other funds holding ABCL

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return